Le Jeune Puetz Investment Counsel LLC Gilead Sciences, Inc. Transaction History

Le Jeune Puetz Investment Counsel LLC

$272 Million
Q1 2023

A detailed history of Le Jeune Puetz Investment Counsel LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Le Jeune Puetz Investment Counsel LLC holds 34,035 shares of GILD stock, worth $2.31 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares

34,035

Previous 34,020 0.04%

Holding current value

$2.31 Million

Previous $2.92 Million 3.32%

% of portfolio

1.04%

Previous 1.12%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$77.31 - $88.08 $1,159 - $1,321	15 Added 0.04%	34,035 $2.82 Million
Q4 2022 Jan 20, 2023	BUY	$62.32 - $89.47 $65,436 - $93,943	1,050 Added 3.18%	34,020 $0
Q3 2022 Nov 08, 2022	BUY	$59.54 - $68.01 $33,342 - $38,085	560 Added 1.73%	32,970 $2.03 Million
Q2 2022 Jul 21, 2022	BUY	$57.72 - $65.01 $237,517 - $267,516	4,115 Added 14.54%	32,410 $2 Million
Q1 2022 May 02, 2022	BUY	$57.92 - $72.58 $27,512 - $34,475	475 Added 1.71%	28,295 $1.68 Million

Q4 2021 Jan 31, 2022	BUY	$64.88 - $73.64 $5,190 - $5,891	80 Added 0.29%	27,820 $2.02 Million
Q3 2021 Oct 26, 2021	BUY	$67.69 - $73.03 $73,782 - $79,602	1,090 Added 4.09%	27,740 $1.94 Million
Q2 2021 Jul 27, 2021	SELL	$63.47 - $69.35 $4,760 - $5,201	-75 Reduced 0.28%	26,650 $1.84 Million
Q1 2021 Apr 26, 2021	BUY	$60.0 - $68.46 $87,000 - $99,266	1,450 Added 5.74%	26,725 $1.73 Million
Q4 2020 Jan 28, 2021	BUY	$56.65 - $64.55 $58,066 - $66,163	1,025 Added 4.23%	25,275 $1.47 Million
Q3 2020 Nov 03, 2020	BUY	$62.1 - $78.08 $40,365 - $50,752	650 Added 2.75%	24,250 $1.53 Million
Q2 2020 Aug 03, 2020	SELL	$72.34 - $84.0 $253,190 - $294,000	-3,500 Reduced 12.92%	23,600 $1.82 Million
Q1 2020 Apr 29, 2020	BUY	$62.63 - $80.22 $146,241 - $187,313	2,335 Added 9.43%	27,100 $2.03 Million
Q4 2019 Jan 28, 2020	SELL	$61.62 - $67.78 $99,824 - $109,803	-1,620 Reduced 6.14%	24,765 $1.61 Million
Q3 2019 Oct 23, 2019	BUY	$62.51 - $69.0 $9,689 - $10,695	155 Added 0.59%	26,385 $1.67 Million
Q2 2019 Jul 29, 2019	BUY	$61.87 - $69.38 $86,618 - $97,132	1,400 Added 5.64%	26,230 $1.77 Million
Q1 2019 Apr 23, 2019	BUY	$62.53 - $70.05 $95,358 - $106,826	1,525 Added 6.54%	24,830 $1.61 Million
Q4 2018 Jan 30, 2019	BUY	$60.54 - $79.0 $155,285 - $202,635	2,565 Added 12.37%	23,305 $1.46 Million
Q3 2018 Oct 29, 2018	BUY	$71.28 - $78.92 $7,128 - $7,892	100 Added 0.48%	20,740 $1.6 Million
Q2 2018 Jul 26, 2018	BUY	$64.88 - $75.68 $11,354 - $13,244	175 Added 0.86%	20,640 $1.46 Million
Q1 2018 Apr 27, 2018	BUY	$72.84 - $88.8 $119,384 - $145,543	1,639 Added 8.71%	20,465 $1.54 Million
Q4 2017 Jan 31, 2018	BUY	$71.15 - $83.52 $49,164 - $57,712	691 Added 3.81%	18,826 $1.35 Million
Q3 2017 Oct 20, 2017	BUY	$72.11 - $85.47 $1.31 Million - $1.55 Million	18,135	18,135 $1.47 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $84.9B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Le Jeune Puetz Investment Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Le Jeune Puetz Investment Counsel LLC with notifications on news.

Account

Le Jeune Puetz Investment Counsel LLC Gilead Sciences, Inc. Transaction History